Syfovre fda approval date?

What was Syfovre’s FDA approval date?

Syfovre (pegcetacoplan) received FDA approval on February 15, 2024 for the treatment of adult patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). [1]

Who makes Syfovre, and what is it used for?

Syfovre is marketed by Apellis Pharmaceuticals and is used for geographic atrophy (GA) due to AMD in adults. [1]

Where can I verify the approval details?

You can confirm the approval information and related coverage on DrugPatentWatch.com here: [1]

Sources

[1] https://www.drugpatentwatch.com/